Australia's TGA takes tough stance on COX-2's

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2005

Schlagwörter:	Arthritis Celecoxib Rofecoxib Meloxicam Etoricoxib

Anmerkung:	© Adis International Ltd 2005

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1475(2005), 1 vom: Feb., Seite 22-22
Übergeordnetes Werk:	volume:1475 ; year:2005 ; number:1 ; month:02 ; pages:22-22

Links:	Volltext

DOI / URN:	10.2165/00128413-200514750-00054

Katalog-ID:	SPR035210117

Internformat


LEADER	01000caa a22002652 4500
001	SPR035210117
003	DE-627
005	20230519215405.0
007	cr uuu---uuuuu
008	201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.2165/00128413-200514750-00054 \|2 doi
035			\|a (DE-627)SPR035210117
035			\|a (SPR)00128413-200514750-00054-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Australia's TGA takes tough stance on COX-2's
264		1	\|c 2005
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 2005
650		4	\|a Arthritis \|7 (dpeaa)DE-He213
650		4	\|a Celecoxib \|7 (dpeaa)DE-He213
650		4	\|a Rofecoxib \|7 (dpeaa)DE-He213
650		4	\|a Meloxicam \|7 (dpeaa)DE-He213
650		4	\|a Etoricoxib \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 1475(2005), 1 vom: Feb., Seite 22-22 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:1475 \|g year:2005 \|g number:1 \|g month:02 \|g pages:22-22
856	4	0	\|u https://dx.doi.org/10.2165/00128413-200514750-00054 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_206
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_4305
951			\|a AR
952			\|d 1475 \|j 2005 \|e 1 \|c 02 \|h 22-22

Indexfelder

matchkey_str	article:22306056:2005----::utaisgtksogsa
hierarchy_sort_str	2005
publishDate	2005
allfields	10.2165/00128413-200514750-00054 doi (DE-627)SPR035210117 (SPR)00128413-200514750-00054-e DE-627 ger DE-627 rakwb eng Australia's TGA takes tough stance on COX-2's 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Arthritis (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Meloxicam (dpeaa)DE-He213 Etoricoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1475(2005), 1 vom: Feb., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1475 year:2005 number:1 month:02 pages:22-22 https://dx.doi.org/10.2165/00128413-200514750-00054 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1475 2005 1 02 22-22
spelling	10.2165/00128413-200514750-00054 doi (DE-627)SPR035210117 (SPR)00128413-200514750-00054-e DE-627 ger DE-627 rakwb eng Australia's TGA takes tough stance on COX-2's 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Arthritis (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Meloxicam (dpeaa)DE-He213 Etoricoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1475(2005), 1 vom: Feb., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1475 year:2005 number:1 month:02 pages:22-22 https://dx.doi.org/10.2165/00128413-200514750-00054 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1475 2005 1 02 22-22
allfields_unstemmed	10.2165/00128413-200514750-00054 doi (DE-627)SPR035210117 (SPR)00128413-200514750-00054-e DE-627 ger DE-627 rakwb eng Australia's TGA takes tough stance on COX-2's 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Arthritis (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Meloxicam (dpeaa)DE-He213 Etoricoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1475(2005), 1 vom: Feb., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1475 year:2005 number:1 month:02 pages:22-22 https://dx.doi.org/10.2165/00128413-200514750-00054 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1475 2005 1 02 22-22
allfieldsGer	10.2165/00128413-200514750-00054 doi (DE-627)SPR035210117 (SPR)00128413-200514750-00054-e DE-627 ger DE-627 rakwb eng Australia's TGA takes tough stance on COX-2's 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Arthritis (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Meloxicam (dpeaa)DE-He213 Etoricoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1475(2005), 1 vom: Feb., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1475 year:2005 number:1 month:02 pages:22-22 https://dx.doi.org/10.2165/00128413-200514750-00054 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1475 2005 1 02 22-22
allfieldsSound	10.2165/00128413-200514750-00054 doi (DE-627)SPR035210117 (SPR)00128413-200514750-00054-e DE-627 ger DE-627 rakwb eng Australia's TGA takes tough stance on COX-2's 2005 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 2005 Arthritis (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Meloxicam (dpeaa)DE-He213 Etoricoxib (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1475(2005), 1 vom: Feb., Seite 22-22 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1475 year:2005 number:1 month:02 pages:22-22 https://dx.doi.org/10.2165/00128413-200514750-00054 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305 AR 1475 2005 1 02 22-22
language	English
source	Enthalten in Inpharma weekly 1475(2005), 1 vom: Feb., Seite 22-22 volume:1475 year:2005 number:1 month:02 pages:22-22
sourceStr	Enthalten in Inpharma weekly 1475(2005), 1 vom: Feb., Seite 22-22 volume:1475 year:2005 number:1 month:02 pages:22-22
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Arthritis Celecoxib Rofecoxib Meloxicam Etoricoxib
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	2005-02-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035210117
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035210117</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519215405.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200514750-00054</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035210117</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200514750-00054-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Australia's TGA takes tough stance on COX-2's</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Celecoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rofecoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Meloxicam</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Etoricoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1475(2005), 1 vom: Feb., Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1475</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200514750-00054</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1475</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Australia's TGA takes tough stance on COX-2's Arthritis (dpeaa)DE-He213 Celecoxib (dpeaa)DE-He213 Rofecoxib (dpeaa)DE-He213 Meloxicam (dpeaa)DE-He213 Etoricoxib (dpeaa)DE-He213
topic	misc Arthritis misc Celecoxib misc Rofecoxib misc Meloxicam misc Etoricoxib
spellingShingle	misc Arthritis misc Celecoxib misc Rofecoxib misc Meloxicam misc Etoricoxib Australia's TGA takes tough stance on COX-2's
topic_unstemmed	misc Arthritis misc Celecoxib misc Rofecoxib misc Meloxicam misc Etoricoxib
topic_browse	misc Arthritis misc Celecoxib misc Rofecoxib misc Meloxicam misc Etoricoxib
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Australia's TGA takes tough stance on COX-2's
ctrlnum	(DE-627)SPR035210117 (SPR)00128413-200514750-00054-e
title_full	Australia's TGA takes tough stance on COX-2's
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	2005
contenttype_str_mv	txt
container_start_page	22
container_volume	1475
format_se	Elektronische Aufsätze
doi_str_mv	10.2165/00128413-200514750-00054
title_sort	australia's tga takes tough stance on cox-2's
title_auth	Australia's TGA takes tough stance on COX-2's
abstract	© Adis International Ltd 2005
abstractGer	© Adis International Ltd 2005
abstract_unstemmed	© Adis International Ltd 2005
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 GBV_ILN_206 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4305
container_issue	1
title_short	Australia's TGA takes tough stance on COX-2's
url	https://dx.doi.org/10.2165/00128413-200514750-00054
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.2165/00128413-200514750-00054
up_date	2024-07-03T13:52:59.642Z
_version_	1803566217579986944
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035210117</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519215405.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2005 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-200514750-00054</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035210117</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-200514750-00054-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Australia's TGA takes tough stance on COX-2's</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2005</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 2005</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arthritis</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Celecoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Rofecoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Meloxicam</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Etoricoxib</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1475(2005), 1 vom: Feb., Seite 22-22</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1475</subfield><subfield code="g">year:2005</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:22-22</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-200514750-00054</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1475</subfield><subfield code="j">2005</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">22-22</subfield></datafield></record></collection>
score	7.399063

Nicht das Richtige dabei?

Schreiben Sie uns!

Australia's TGA takes tough stance on COX-2's

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?